SALL2 and cancer: Breast MDA-MB-231 and colon SW480 cancer cells were selected based on the fact that there is no reported deletion or transcriptional silencing of the SALL2 gene -as opposed to SK-OV-3 and HL-60 cell lines [24, 25], suggesting that the selected cells have the capacity to generate the protein product.